MedPath

A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

Phase 4
Completed
Conditions
Open-Angle Glaucoma
Interventions
Device: iStent
Registration Number
NCT00326014
Lead Sponsor
Glaukos Corporation
Brief Summary

To evaluate the safety and efficacy of a new trabecular bypass that is implanted in conjunction with cataract surgery in open angle glaucoma subjects.

Detailed Description

Glaukos Corporation conducted a clinical research study at multiple investigational sites within Europe (8)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Diagnosed with primary open-angle glaucoma (POAG)
  • Subject on at least one glaucoma medication
  • Patient requiring cataract surgery and an intraocular lens implantation
Exclusion Criteria
  • Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc)
  • Angle closure glaucoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AiStent-
Primary Outcome Measures
NameTimeMethod
Efficacy24 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Universitats Augenklinik

🇩🇪

Freiburg, Germany

Clinico San Carlos

🇪🇸

Madrid, Spain

Rotkreuz Krankenhaus

🇩🇪

München, Germany

Klinikum Neubrandenburg

🇩🇪

Neubrandenburg, Germany

Klinik Vincentinum

🇩🇪

Augsburg, Germany

Augenaerztliche Gemeinschaftspraxis

🇩🇪

Weinheim, Germany

Instituto Oftalmológico de Aragón

🇪🇸

Zaragoza, Spain

Augenklinik Kantonsspital

🇨🇭

Winterthur, Switzerland

© Copyright 2025. All Rights Reserved by MedPath